Patents by Inventor Yuichi SAWAGUCHI

Yuichi SAWAGUCHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11542273
    Abstract: Provided are a compound superior in a cytotoxic action on cancer cells, an action inducing degradation of BET protein in cancer cells, and an inhibitory action on the binding of BET protein and acetylated histone, and useful as an anticancer agent, a BET protein degradation inducer or a BET protein inhibitor. A compound represented by the following formula (I) wherein each symbol is as defined in the specification, or a pharmacologically acceptable salt thereof.
    Type: Grant
    Filed: July 4, 2019
    Date of Patent: January 3, 2023
    Assignee: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Ryuta Yamazaki, Tatsuya Ibuki, Yuichi Sawaguchi, Kiyomi Ohba, Maiko Hamada, Yasuki Niwa, Yuko Ishida, Hideto Maruyama, Shiki Matsuki, Minoru Tanaka
  • Publication number: 20210284654
    Abstract: Provided are a compound superior in a cytotoxic action on cancer cells, an action inducing degradation of BET protein in cancer cells, and an inhibitory action on the binding of BET protein and acetylated histone, and useful as an anticancer agent, a BET protein degradation inducer or a BET protein inhibitor.
    Type: Application
    Filed: July 4, 2019
    Publication date: September 16, 2021
    Applicants: MITSUBISHI TANABE PHARMA CORPORATION, KABUSHIKI KAISHA YAKULT HONSHA
    Inventors: Ryuta YAMAZAKI, Tatsuya IBUKI, Yuichi SAWAGUCHI, Kiyomi OHBA, Maiko HAMADA, Yasuki NIWA, Yuko ISHIDA, Hideto MARUYAMA, Shiki MATSUKI, Minoru TANAKA